<?xml version="1.0" encoding="UTF-8"?><template xmlns="openEHR/v1/Template" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><id>16041816-9b57-422a-b5a8-3bcad184df67</id><name>This is a Formulary Restricted drug. Which restriction does this patient meet 408000185 Question</name><description><lifecycle_state>Initial</lifecycle_state><details><purpose/><use/><misuse/></details><other_details><item><key>MetaDataSet:Build</key><value>Build details</value></item><item><key>Acknowledgemet</key><value/></item><item><key>Analyst</key><value/></item><item><key>Attachments regarding build</key><value/></item><item><key>Build complete date</key><value/></item><item><key>Build team</key><value/></item><item><key>Comments</key><value/></item><item><key>Record name</key><value/></item><item><key>To ananlyst date</key><value/></item></other_details></description><annotations path="[openEHR-EHR-CLUSTER.freetextorderquestion.v1]"><items><item><key>Order Specific Questions.Question ID</key><value>&lt;p&gt;408000185&lt;/p&gt;</value></item><item><key>Order Specific Questions.Question Name</key><value>&lt;p&gt;AHS WIP RIVAROXABAN TABLET&lt;/p&gt;</value></item><item><key>Order Specific Questions.Question</key><value>&lt;p&gt;This is a Formulary Restricted drug. Which restriction does this patient meet?&lt;/p&gt;</value></item><item><key>Technical.ï»© Technical Traceability</key><value>{~AHSID~16041816-9b57-422a-b5a8-3bcad184df67~NAME~This is a Formulary Restricted drug. Which restriction does this patient meet 408000185 Question}</value></item></items></annotations><annotations path="[openEHR-EHR-CLUSTER.freetextorderquestion.v1]/items[at0001]"><items><item><key>Order Specific Questions.Answer Button Values</key><value>
						&lt;p&gt;2.5 mg: patient has coronary artery disease (CAD) AND peripheral artery disease (PAD)&lt;/p&gt;
					
						&lt;p&gt;10 mg: Venous thromboembolic (VTE) Prophylaxis post hip/knee replacement&lt;/p&gt;
					
						&lt;p&gt;15 mg or 20 mg: Venous thromboembolic (VTE) treatment&lt;/p&gt;
					
						&lt;p&gt;15 mg or 20 mg: Prevention of stroke or systemic embolism when warfarin can not be used&lt;/p&gt;
					
						&lt;p&gt;Patient stabilized on rivaroxaban prior to admission&lt;/p&gt;
					
						&lt;p&gt;None (Non-Formulary)&lt;/p&gt;
					</value></item><item><key>Order Specific Questions.Cascading - Comparison Operator</key><value>
						&lt;p&gt;1. Equals&lt;/p&gt;
					</value></item><item><key>Order Specific Questions.Cascading - Condition Value</key><value>
						&lt;p&gt;1. None (Non-Formulary)&lt;/p&gt;
					</value></item><item><key>Order Specific Questions.Cascading - Condition Comparison</key><value>
						&lt;p&gt;1. Or&lt;/p&gt;
					</value></item><item><key>Order Specific Questions.Cascading - Questions</key><value>
						&lt;p&gt;1. 408000166&lt;/p&gt;
					</value></item><item><key>Order Specific Questions.Cascading - Questions Record Name</key><value>
						&lt;p&gt;1. AHS WIP NON FORMULARY EXCEPTION&lt;/p&gt;
					</value></item><item><key>Order Specific Questions.Hide Comments</key><value>&lt;p&gt;Yes&lt;/p&gt;</value></item><item><key>Order Specific Questions.Multiple Response</key><value>&lt;p&gt;No&lt;/p&gt;</value></item><item><key>Order Specific Questions.Released Flag</key><value>&lt;p&gt;Yes&lt;/p&gt;</value></item><item><key>Order Specific Questions.Require Response</key><value>&lt;p&gt;Yes&lt;/p&gt;</value></item><item><key>Order Specific Questions.Response Type</key><value>&lt;p&gt;Custom List&lt;/p&gt;</value></item></items></annotations><definition xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1" concept_name="Freetextorderquestion" max="1" name="This is a Formulary Restricted drug. Which restriction does this patient meet?"><Rule path="/items[at0001]"><constraint xsi:type="textConstraint"><includedValues>2.5 mg: patient has coronary artery disease (CAD) AND peripheral artery disease (PAD)</includedValues><includedValues>10 mg: Venous thromboembolic (VTE) Prophylaxis post hip/knee replacement</includedValues><includedValues>15 mg or 20 mg: Venous thromboembolic (VTE) treatment</includedValues><includedValues>15 mg or 20 mg: Prevention of stroke or systemic embolism when warfarin can not be used</includedValues><includedValues>Patient stabilized on rivaroxaban prior to admission</includedValues><includedValues>None (Non-Formulary)</includedValues></constraint></Rule><Items xsi:type="CLUSTER" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1" template_id="341047a5-d7d0-4cc4-a4bb-127974818964" concept_name="Exception Code 408000166 Question" max="1" path="/items[at0002]" name="Exception Code:"/></definition><integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.freetextorderquestion.v1"><digest id="MD5-CAM-1.0.1">5DC6E2FC9E91ADD05E7C5B3E06F83D23</digest></integrity_checks></template>